, raising the possibility that YAP itself induces secretion of the required growth factors or cytokines in these cells. To test this hypothesis, we performed mixing experiments with cells transduced with either GFP-labelled YAP or a red-Cherry-tagged vector. MCF10A cells expressing GFP-YAP, but not Cherry-vector, formed acini in 3D cultures, in the absence of exogenous EGF. Remarkably, vector-transduced cells did produce acini when cocultured in a 1:1 ratio with YAP-expressing cells (Fig. 1a) . Thus, ectopic expression of YAP in MCF10A cells seems to result in secretion of factors that enable the proliferation of neighbouring untransduced cells.
Normal cells require mitogenic growth signals to proliferate, whereas tumour cells often generate their own proliferative signals through the secretion of growth factors or the activation of growth factor receptors 11 . We have shown that YAP-transduced MCF10A cells proliferate in 3D cultures to form acini in the absence of EGF 7 . MCF10A cells are immortalized, non transformed human mammary epithelial cells, which show dependence on growth factors for proliferation and survival 12 , raising the possibility that YAP itself induces secretion of the required growth factors or cytokines in these cells. To test this hypothesis, we performed mixing experiments with cells transduced with either GFP-labelled YAP or a red-Cherry-tagged vector. MCF10A cells expressing GFP-YAP, but not Cherry-vector, formed acini in 3D cultures, in the absence of exogenous EGF. Remarkably, vector-transduced cells did produce acini when cocultured in a 1:1 ratio with YAP-expressing cells (Fig. 1a) . Thus, ectopic expression of YAP in MCF10A cells seems to result in secretion of factors that enable the proliferation of neighbouring untransduced cells.
To identify mediators of this apparent YAP-induced non-cell-autonomous effect, we made use of a constitutively active YAP mutant, YAP S127A . Mutation of the serine residue that is targeted for phosphorylation by the negative regulatory kinases LATS1 and 2 prevents cytoplasmic sequestration of YAP by 14-3-3 proteins 5, 10 , thus resulting in its exclusively nuclear localization ( Supplementary Information, Fig. S1a ). Retroviral vectors containing wild-type YAP or YAP S127A induced similar levels of protein expression (Fig. 1b) . Ectopic expression of YAP S127A induced a strong EMT and cell migration phenotype ( Supplementary Information, Fig. S1b, c) , and robustly promoted EGF-independent acinar growth of MCF10A in 3D cultures (Fig. 1b) . The enhanced YAP phenotype shown by YAP S127A -expressing cells also led to an increased effect in co-culturing experiments, with YAP S127A -expressing MCF10A cells dramatically stimulating acini formation of the neighbouring vector-transfected cells (Fig. 1a) .
To further test whether YAP-expressing cells release growth-inducing factors, we collected conditioned medium from 3D cultures and applied it onto parental MCF10A cells in 3D culture assays. Conditioned media derived from cells transduced with wild-type YAP, and to an even greater extent YAP S127A , but not vector, enabled MCF10A acini formation in the absence of EGF (Fig. 1c) , supporting the existence of a diffusible factor that mediates this non-cell-autonomous effect.
To identify the putative factors secreted by YAP-expressing MCF10A cells, we applied conditioned media onto a cytokine antibody array representing 41 growth factors and cytokines 13 . When media collected from cells grown under standard 3D growth conditions (including EGF supplementation, which allowed acini formation by parental MCF10A cells) was analysed, no significant differences were observed between media from vector-and YAP S127A -transduced cells (Fig. 2a) . However, conditioned media collected from these cultures in the absence of EGF supplementation revealed four proteins that were highly enriched in YAP S127A -transduced cells (threefold more than vector-transduced cells): AREG, insulin-like growth factor binding protein-6 (IGFBP6), plateletderived growth factor-AA (PDGF-AA) and macrophage colony-stimulating factor-receptor (M-CSF-R; Fig. 2a ). To test whether these proteins were specifically induced by YAP, and not by-products of 3D acini formation, we analysed vector-expressing versus YAP S127A -expressing MCF10A cells grown in 2D monolayer cultures, 12 h after withdrawal of EGF. We observed that only AREG was dramatically induced in YAP S127A cells as determined by immunoblotting analysis (Fig. 2b) . AREG thus constitutes the primary candidate for a YAP-induced secreted factor involved in cellular proliferation.
To test whether AREG is a transcriptional target of YAP, we first measured AREG mRNA in YAP S127A -transduced cells. A fivefold increase in the AREG transcript was observed in these cells relative to vector-transduced cells, cultured in the absence of EGF (Fig. 2c) . Binding of YAP to the AREG promoter in vivo was demonstrated by chromatin immunoprecipitation (ChIP) assays. Chromatin, immunoprecipitated with an anti-YAP antibody, yielded strong and reproducible PCR amplification of an AREG-promoter fragment (Fig. 2d) , comparable to that observed for the promoter of CTGF, a known YAP target gene 9, 14 . Given the identification of AREG as a transcriptional target of YAP, we undertook a series of experiments to test the functional consequences of this interaction. We first tested whether neutralizing antibodies against AREG suppressed YAP-mediated 3D acini formation. Addition of anti-AREG IgG (1 μg ml -1 ) suppressed acini formation of YAP S127A -expressing cells by 90%, whereas blocking antibodies against IGFBP6, PDGF-AA or M-CSF-R had no effect (Fig. 2e) . AREG therefore contributed to YAP-mediated proliferation in this assay. To test whether AREG alone is sufficient to mediate the 3D growth of MCF10A cells, we added recombinant AREG to cultures of parental MCF10A cells. A dose-dependent effect of AREG was evident, equivalent to that of EGF in generating 3D acini (Fig. 3a) .
To determine whether YAP-induced secretion of AREG is associated with increased ErbB receptor family signalling, we added lysates from YAP S127A -transduced cells to an EGFR phosphorylation antibody array. In the presence of exogenous EGF, the phosphorylation states of the 17 ErbB phosphorylation sites investigated by this array were comparable between vector and YAP-S127A transduced cells (Fig. 3b) . However, in the absence of EGF, cellular lysates from YAP S127A -transduced cells showed significantly increased phosphorylation of the classic EGFR target residues, EGFR Tyr 845, Tyr 1068 and Tyr 1148, as well as several residues within ErbB-2, ErbB-3 and ErbB-4 (Fig. 3b) . Of note, EGFR activation by AREG in some cell types has been reported to involve an autocrine loop culminating in EGFR-dependent AREG induction 15 . To exclude such a mechanism, we measured AREG levels in the presence or absence of erlotinib, a kinase-specific inhibitor of EGFR. Efficient inhibition of EGFR signalling had no effect on YAP-mediated AREG induction (Fig. 3c, d ). Thus, AREG induction by YAP seems to result from a direct transcriptional mechanism rather than from an EGFR-dependent feedback loop. Erlotinib treatment almost completely abrogated 3D acini formation by YAP S127A -transduced cells (Fig. 3e) , further supporting a key role of EGFR signalling in YAP-mediated proliferation.
Ectopic overexpression of YAP mimics the effect of gene amplification in cancer. However, to model physiological activation of the Hippo pathway, we made use of ACHN kidney cancer cells, in which homozygous deletion of the upstream negative regulator Salvador leads to elevated endogenous YAP activity 5, 10, 16 . Knockdown of YAP in these cells led to a significant reduction in baseline AREG expression (Fig. 3f) . YAP activity is inhibited by the upstream kinases LATS1 and 2, which mediate the cytoplasmic retention of YAP 5, 6, 10 . To test whether physiological activation of YAP through abrogation of LATS1 and 2 leads to induction of AREG, we knocked down LATS1 and 2 transcripts in MCF10A cells, which resulted in a dramatic induction of AREG expression (Fig. 3g) . Taken together, these observations demonstrate regulation of endogenous AREG expression by YAP and its induction by specific disruption of multiple levels of the Hippo pathway.
To test the contribution of AREG induction to the various YAPmediated phenotypes, we made use of lentiviral short hairpin RNA (shRNA)-mediated knockdown constructs targeting AREG itself. In addition to 3D acini formation, YAP-dependent phenotypes in MCF10A cells include the induction of EMT and increased cellular migration. Efficient knockdown of both baseline and YAP S127A -induced AREG expression (both precursor and cleaved AREG) was accomplished using two independent AREG-targeting constructs (Fig. 4a) . YAP-induced phosphorylation of the downstream signalling molecules AKT and ERK was effectively suppressed by AREG knockdown, demonstrating disruption of an autocrine pathway in these cells (Fig. 4a) . As expected, both AREG-targeting constructs also dramatically inhibited EGF-independent 3D acini formation (Fig. 4b) . In addition, suppression of AREG dramatically inhibited cell migration induced by both wild-type YAP and YAP S127A (Fig. 4c) . In contrast, knockdown of AREG had no effect on expression of EMT-related markers (Fig. 4d) , suggesting that AREG may not contribute to this distinct YAP-dependent effect.
Connective tissue growth factor (CTGF) has been recently identified as a transcriptional target of YAP together with the transcription factor TEAD, and they contribute to YAP-mediated EMT 14 . To test whether CTGF has a role in the YAP-dependent non-cell-autonomous effect studied here, we targeted CTGF expression in YAP-transduced MCF10A cells using two independent lentiviral shRNA constructs. Efficient knockdown of CTGF was accomplished, but had no effect on YAP-mediated acini formation ( Supplementary Information, Fig. S2a, b) . Therefore, CTGF and AREG may serve as complementary effectors of YAP, mediating distinct downstream phenotypes.
The complex Hippo pathway shows a high degree of evolutionary conservation from Drosophila, where it was first revealed, to mammals. Despite the fact that the components of the pathway leading to activation of mammalian YAP and Drosophila yki are highly conserved 1, 2 , the downstream effectors of yki that have been identified so far in Drosophila screens do not seem to be similarly regulated in mammalian cells 5, 9 . We therefore asked whether the components of the EGFR pathway interact genetically with the core factors of the Drosophila Hippo pathway.
EGFR signalling in Drosophila involves one receptor, Egfr, and four Egfr ligands: Spitz, Keren, Gurken and Vein 17 . To test for genetic interactions, we first crossed flies carrying mutations in EGFR, EGFR ligands or EGFR-processing proteins 17 with flies harbouring mutations in the Hippo pathway, including warts (wts) and hippo (hpo), the negative regulators of yki, which were overexpressed under the control of an eyespecific promoter (GMR). Consistent with a previous report 16 , GMR-wts eyes were normal in appearance (Fig. 5b) , comparable with wild-type eyes (Fig. 5a) . A rough eye phenotype was evident when GMR-wts was combined with a heterozygous loss-of-function mutation of Egfr which itself did not have a phenotype (Fig. 5c) . A similar synthetic interaction was also observed when GMR-wts was combined with several other loss-of-function alleles of Egfr ( Supplementary Information, Table S1 ), or with a mutant allele of vein, an EGFR ligand (Fig. 5d) . In contrast, mutant alleles of other EGFR ligands, such as spitz, keren and gurken, produced no synergistic effect ( Supplementary Information, Table S1 ). We carried out a second set of genetic tests combining GMR-hpo with EGFR-pathway components. Unlike GMR-wts, the eye-specific overexpression of hpo generates a small, rough eye phenotype, in which the regular ommatidial organization is disrupted but individual ommatidia can still be distinguished 18 (Fig. 5e ). When combined with heterozygous mutations of Egfr (Fig. 5f) or vein (Fig. 5g) , the ommatidial organization was more severely disrupted: the eyes had a glassy appearance and fused ommatidia were apparent (Fig. 5f, g ), suggesting that mutant alleles of Egfr and vein dominantly enhanced the GMR-hpo rough eye phenotype. In contrast, mutant alleles of spitz, keren or gurken had no such effect (Supplementary Information, Table S1 ). In a third set of genetic analyses, we used the previously reported GMR-yki phenotype 19 ( Supplementary Information, Fig. S3b ), which causes a bulgy, rough eye phenotype. This yki overgrowth phenotype was partially suppressed by heterozygous loss-of-function alleles of Egfr ( Supplementary  Information, Fig. S3c) . Again, partial suppression of this phenotype was observed with mutant alleles of vein, but not with mutant alleles of the other three EGFR ligands, that is, spitz, keren or gurken (Supplementary Information, Table S1 ). Taken together, these genetic crosses indicate that increased activity of the Drosophila YAP orthologue, yki, can be partially suppressed by Egfr-pathway mutants, whereas reduced activity of the yki pathway resulting from overexpression of the negative regulators wts and hpo is enhanced by loss of function of the Egfr pathway.
To investigate the molecular mechanisms by which the Hpo and Egfr signalling pathways interact in Drosophila, we measured phospho-ERK activity by immunoblotting of wing imaginal discs ectopically expressing constitutively active form of human YAP S127A (genotype, w; nubbin-Gal4/ UAS-YAP S127A ; +). Increased phospho-ERK levels were observed in YAP S127A wing discs (Fig. 5h) , consistent with activation of Egfr signalling.
To determine whether any of the Egfr ligands are induced by Drosophila Yki, we tested their expression using quantitative reverse transcription-PCR (qRT-PCR) in eye discs ectopically expressing the constitutively active form of Yki 19 (Yki S168A , equivalent to YAP S127A ); genotype, yw eyFlp/+; tub>y+>yki S168A /+). Among Egfr ligands, only vein showed moderate, but reproducible, increased expression in yki-activated clones (Fig. 5i) . The selective effect on this Egfr ligand is particularly interesting in that it is consistent with the genetic interactions between the yki and Egfr pathways as described above. These genetic studies also implicated vein, but not other ligands, as a modifier of the Hippo phenotypes ( Supplementary Information, Table S1 ). Taken together, our results suggest interactions between the Hippo and Egfr pathways in Drosophila that are compatible with the functional relationship identified in mammalian cells. As genetic interactions are often complex, further studies will be necessary to determine whether vein expression is directly regulated by Yki, or altered indirectly. Nevertheless, these results suggest that the selective induction of an Egfr ligand by Yki may contribute to the interplay between Egfr and Hippo pathways in Drosophila. Unlike in mammalian cells, where YAP effectors have been implicated in cell autonomous pathways, secreted ligands other than YAP effectors have been linked to the Drosophila Hippo pathway. Yki activation leads to activation of Wingless, a ligand for the Wnt pathway, and Serrate, a ligand for the Notch pathway 20, 21 . Loss of the upstream Hippo component fat also results in activation of Egfr signalling 22 . Activation of Egfr signalling through AREG secretion in mammalian cells may thus represent an evolutionarily conserved feature of the Hippo pathway.
In summary, the EGFR ligand AREG seems to be a downstream effector of the Hippo pathway and a direct target of YAP. Although the role of YAP in mammalian systems was first established through tumorigenesis studies, it has been recently linked to the regulation of progenitor cell pools and organ size during liver regeneration 4, 5 . As such, YAP target genes may have important roles in both physiological and malignant proliferation signals. YAP target genes have been investigated by gene expression profiling in MCF10A cells and in the mouse 5, 6, 9, 14 . Interestingly, AREG is among potential targets listed in these screens in MCF10A cells. YAP-mediated transcriptional induction is thought to involve its binding to known transcription factors, including p73, Runx2 and TEAD family members 1, 2, 23 . Our ChIP experiments were unable to identify binding sites for these transcription factors in the AREG promoter (data not shown), pointing to potential additional transcriptional partners for YAP in mediating AREG induction.
Like YAP, AREG overexpression has been implicated in both normal organ proliferation and malignancy. In addition to its secretion by many cancer cell lines [24] [25] [26] , AREG mediates protection against liver injury in a mouse model 27 , and in the breast, it is a key mediator of oestrogen-induced pubertal epithelial morphogenesis. Mouse knockouts Immunoblotting of dpERK was performed using wing imaginal discs from either control flies (w 1118 ) or wing discs from YAP S127A -overexpressing flies (genotype: nubbin-Gal4/UAS-YAP S127A ). β-Tubulin was used as a loading control. (i) qRT-PCR analysis of Egfr ligands using eye discs either from control (w 1118 ) or Yki S168A -expressing flies (genotype: yw eyFlp/+; tub>w+>yki SA /+). Ct (cycle threshold) volume normalized by ribosomal protein 49; β-Tubulin expression was used as an internal negative control. *P < 0.001, **P < 0.003 (Student's t-test). For a full scan of the blot in h, see Supplementary Information, Fig. S4 .
of oestrogen receptor alpha, AREG and EGFR all show similar defects in mammary gland development 28 . Thus, in the breast and potentially other tissues, AREG may mediate both developmentally regulated proliferation and malignant transformation, consistent with its contribution to the broad role of YAP and the Hippo pathway in the regulation of cellular homeostasis. The fact that YAP may mediate some of its key functions through a secreted growth factor implicates a non-cellautonomous mechanism that may contribute to the expansion of both normal and malignant progenitors, raising the possibility of eventual therapeutic applications.
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M E T H O D S
METHODS
Cell culture and transfections. MCF10A cell culture and 3D culture were performed as described previously 29 . ACHN cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM L-glutamine and 50 U ml -1 penicillin/streptomycin, and incubated at 5% CO 2 at 37 °C. A transwell cell migration assay was performed as described previously 7 . For knockdown studies, shRNA targeting human YAP and AREG were obtained from the RNAi Consortium (Broad Institute). Forward oligonucleotide sequences are listed: shYAP-A, 5′-CCGGCCCA GTTAAATGTTCACCAATCTCGAGATT GGTGAACATTTAACTGGGTTTTTG-3′; shYAP-B, 5′-CCGGGCCA CCAAG CTAGATAAAGAACTCGAGTTCTTTATCTAGCTTGGTGGCTTTTTG-3′; shAREG-A9, 5′-CCGGCAC TGCCAAGTCATAGCCATACTCGAGTATGGCTA TGACTTGGCAGTGTTTTTG-3′; shAREG-G12, 5′-CCGGGAACG A AAGAAA CTTCGACAACTCGAGTTGTCGAAGTTTCTTTCGTTCTTTTTG-3′; control shRNA, 5′-CCGGCAAC AAGATGAAGAGCACCAACTCGAGTTGGTGCT-CTTCATCTTGTTGTTTTT-3′. shCTGF-1 and shCTGF-2 are as previously reported 14 . Lentivirus packaging, MCF10A cell transduction and drug selection were performed following standard protocols. Human YAP expression construct was described previously 7 ; YAP S127A expression construct was synthesized by PCR-based mutagenesis. siRNA experiments were performed as described previously 9 . For RNA preparation and qRT-PCR detection, RNA was extracted using the RNeasy Mini Kit (Qiagen). cDNA synthesis was performed using First-Strand cDNA Synthesis Kit (GE Healthcare) and quantitative real-time PCR was performed using Power SYBR Green PCR Master Mix (Applied Biosystems).
Sequences of the qPCR primer pairs were as follows: GAPDH-F, 5′-GGTGAAGGTCGGAGTCAACGG-3′; GAPDH-R, 5′-GAGGTCAATGAA-GGGGTCATTG-3′; YAP-F, 5′-CCTTCTTC AAGCCG CCGGAG-3′;
YAP-R, 5′-CAGTGTCCCAGGAGAAACAGC-3′; AREG-F, 5′-CGAACC-ACAAATACCTGGCTA-3′; AREG-R, 5′-TCCATTTTT GCCTCCCTTTT-3′;
IGFBP6-F, 5′-CACTGCCCGCCCACAGGATGTG-3′; IGFBP6-R, 5′-CTC-GG T AGACCTCAGTCTGGAG-3′; PDGFAA-F, 5′-GGGGTCCA TGCCACTA-AGCATGTGC-3′; PDGF-AA-R, 5′-GGAATCTCGT AAATGACC GTCC-3′; M-CSF1-R-F, 5′-CAGGAAGGT GATGTCCATCAGC-3′; M-CSF1-R-R, 5′-CCAGCTCTGCAGGCACCAG-3′. All measurements were performed in triplicate and standardized to the levels of GAPDH.
Sequences of the qPCR primer pairs for flies were as follows: Rp49-F, 5′-ACAGGCCCAAGATCGTGAAGA-3′; Rp49-R, 5′-CGCACTCT-GTTGTCGATACCCT-3′; Tubulin-F, 5′-AGACCTACTGCATCGACAAC-3′; Tubulin-R, 5′-GACAAGATGGTTCAGGTCAC-3′; Yki-F, 5′-GCGCCTTGCCG-CCGGGATG-3′; Yki-R, 5′-GCTGGCGATATTGGATTCTG-3′; Grk-F, 5′-CTGTTGCGACGCCAAATTG-3′; Grk-R, 5′-CCGATT GTCCACCAC-TAGGAAA-3′; Krn-F, 5′-CTGCATTGCCACATTCCCA-3′; Krn-R, 5′-CGGTAGGTAAGCGCCGATTAA-3′; Spi-F, 5′-AGGAACT GCAGCAGG-AATACGA-3′; Spi-R, 5′-AGCTTG CGCTCCAGAATGACT-3′; Vn-F, 5′-ATCAA-GCATGGAAAGAAGCTGC-3′; Vn-R, 5′-CGCTTGC GATTGATGGACTT-3′.
Chromatin immunoprecipitation (ChIP). Assays were performed as described previously 30 . Briefly, MCF10A cells transduced with YAP S127A retrovirus were crosslinked, lysed and sonicated to generate DNA fragments with an average size of 0.5 kb. The immunoprecipitation was performed using 1 μg ml -1 of antibody against IgG or YAP (Santa Cruz). Sequences of ChIP PCR primers were: AREG-F, 5′-CCAAAAGAATCTTTTGAAATCTTTGGGC-3′; AREG-R, 5′-GTGAGGGTATGACCAAGTATGGGAAATAAG-3′. Sequences of the CTGF PCR primers were as reported previously Table S1 ). Immunoblotting of dpERK 31 was performed by dissecting the wing imaginal discs from third instar larvae, either control (w 1118 ) or nubbin-Gal4/UAS-YAP S127A . qRT-PCR analysis of Egfr ligands was carried out using eye discs from either control (w 1118 ) or Yki S168A overexpression third instar larvae (genotype: yw eyFlp/+; tub>w + >yki SA /+). Standard protocols were followed for both western blotting and qRT-PCR. Primers for qRT-PCR are listed under ' Antibodies and molecular analyses' . nature cell biology 
